XML 81 R61.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
May 26, 2020
Jan. 01, 2020
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Sep. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Weighted average grant date fair value, grants in period (in usd per share)     $ 49.73 $ 55.16 $ 46.85 $ 53.02    
Stock based compensation not recognized, options     $ 21,000   $ 21,000      
Stock based compensation not recognized, period for recognition (years)         2 years 6 months      
Total market-based restricted stock units approved and granted         114,472      
Stock-based compensation     $ 55,198 $ 5,484 $ 87,351 $ 11,882    
Common stock, shares reserved for future issuance (in shares)     8,277,673   8,277,673   8,407,162  
Class B | AMEA 2020 Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Weighted average grant date fair value, grants in period (in usd per share)     $ 0.33   $ 0.33      
Stock based compensation not recognized, options     $ 700   $ 700      
Stock based compensation not recognized, period for recognition (years)         2 years 4 months 24 days      
Total market-based restricted stock units approved and granted         3,902,224      
Shares authorized (in shares)         4,595,555      
Guardant Health AMEA, Inc | Class B | AMEA 2020 Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Common stock, shares reserved for future issuance (in shares)     4,595,555   4,595,555      
Guardant Health AMEA, Inc | Class B | AMEA 2020 Plan | Tranche One                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Market-based stock unit vesting period         4 years      
Option term, expiration period         10 years      
Guardant Health AMEA, Inc | Class B | AMEA 2020 Plan | Tranche Two                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Purchase price of common stock (as a percent of the fair value of common stock)         110.00%      
Option term, expiration period         5 years      
Threshold percentage for individual's combined voting power triggering five year option term         10.00%      
Stock options issued and outstanding                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Exercises in period, intrinsic value     $ 46,800 $ 75,300 $ 97,100 $ 191,700    
Common stock, shares reserved for future issuance (in shares)     3,356,774   3,356,774   4,494,889  
Expected dividend yield     0.00% 0.00% 0.00% 0.00%    
Stock options issued and outstanding | Maximum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Expected volatility     68.40% 64.60% 73.30% 68.30%    
Risk-free interest rate     0.40% 1.90% 1.60% 2.70%    
Stock options issued and outstanding | Minimum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Expected volatility     63.60% 63.20% 63.60% 63.20%    
Risk-free interest rate     0.30% 1.60% 0.30% 1.60%    
Shares underlying unvested restricted stock units                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock based compensation not recognized, period for recognition (years)         3 years 4 months 24 days      
Stock based compensation not recognized, other than options     $ 77,100   $ 77,100      
Common stock, shares reserved for future issuance (in shares)     949,276   949,276   496,131  
ESPP shares granted (in shares)         601,451      
MSUs                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock based compensation not recognized, period for recognition (years)         1 year 1 month 6 days      
Stock based compensation not recognized, other than options     $ 162,100   $ 162,100      
Total market-based restricted stock units approved and granted         3,391,148      
Market-based restricted stock share price goal 30 days              
Market-based stock unit vesting period 7 years              
Weighted average grant date fair value of MSU (in usd per share)         $ 67.00      
Stock-based compensation     46,800   $ 65,100      
Expected dividend yield         0.00%      
Expected volatility         65.50%      
Risk-free interest rate         0.53%      
Risky rate, cost of equity         0.16      
MSUs | Chief Executive Officer                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Total market-based restricted stock units approved and granted 1,695,574              
MSUs | President and Chief Operating Officer                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Total market-based restricted stock units approved and granted 1,695,574              
MSUs | Maximum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Market-based stock units holding period during vesting 12 months              
Weighted-average derivative service period         2 years 25 days      
Discount for post-vesting restrictions         14.50%      
MSUs | Minimum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Market-based stock units holding period during vesting 6 months              
Weighted-average derivative service period         9 months 29 days      
Discount for post-vesting restrictions         10.40%      
Shares available for issuance under the 2018 Employee Stock Purchase Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock based compensation not recognized, period for recognition (years)         1 month 6 days      
Stock based compensation not recognized, other than options     400   $ 400      
Stock-based compensation     $ 700 $ 800 $ 2,300 $ 1,800    
Purchase price of common stock (as a percent of the fair value of common stock)         85.00%      
Common stock, shares reserved for future issuance (in shares)     1,574,367   1,574,367   689,917 922,250
Expected dividend yield       0.00% 0.00% 0.00%    
Expected volatility       60.30% 73.20%      
Risk-free interest rate       2.10% 0.20%      
Shares authorized (in shares)   942,614            
Maximum employee subscription rate, ESPP     10.00%   10.00%      
Common stock issued under employee stock purchase plan (in shares)     0 93,203 58,164 212,905    
ESPP shares granted (in shares)     0          
Shares available for issuance under the 2018 Employee Stock Purchase Plan | Maximum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Expected volatility           60.30%    
Risk-free interest rate           2.50%    
Shares available for issuance under the 2018 Employee Stock Purchase Plan | Minimum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Expected volatility           60.20%    
Risk-free interest rate           2.10%    
Employee Stock Option, Early Exercise                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock subject to repurchase (in shares)         15,681   23,981  
Stock subject to repurchase, per share (in usd per share)     $ 4.66   $ 4.66   $ 4.66  
Cash proceeds received for unvested shares     $ 100   $ 100   $ 100